Phathom Pharmaceuticals (PHAT) said Tuesday that it has named Steven Basta as its new chief executive officer and president, effect immediately.
He succeeds Terrie Curran, who served as CEO for five years before leaving for personal reasons, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.